scispace - formally typeset
Journal ArticleDOI

Epidemiology of breast cancer.

Timothy J. Key, +2 more
- 01 Mar 2001 - 
- Vol. 2, Iss: 3, pp 133-140
Reads0
Chats0
TLDR
Both oral contraceptives and hormonal therapy for menopause cause a small increase in breast-cancer risk, which appears to diminish once use stops, and alcohol increases risk, whereas physical activity is probably protective.
Abstract
Summary Breast cancer is the commonest cause of cancer death in women worldwide. Rates vary about five-fold around the world, but they are increasing in regions that until recently had low rates of the disease. Many of the established risk factors are linked to oestrogens. Risk is increased by early menarche, late menopause, and obesity in postmenopausal women, and prospective studies have shown that high concentrations of endogenous oestradiol are associated with an increase in risk. Childbearing reduces risk, with greater protection for early first birth and a larger number of births; breastfeeding probably has a protective effect. Both oral contraceptives and hormonal therapy for menopause cause a small increase in breast-cancer risk, which appears to diminish once use stops. Alcohol increases risk, whereas physical activity is probably protective. Mutations in certain genes greatly increase breastcancer risk, but these account for a minority of cases.

read more

Citations
More filters
Journal ArticleDOI

A life course approach to chronic disease epidemiology

TL;DR: It is underscore that a life course approach offers a way to conceptualize how underlying socio-environmental determinants of health, experienced at different life course stages, can differentially influence the development of chronic diseases, as mediated through proximal specific biological processes.
Journal ArticleDOI

Diet, nutrition and the prevention of cancer

TL;DR: Overweight/obesity increases the risk for cancers of the oesophagus, colorectum, breast, breast (postmenopausal), endometrium and kidney, and diets should include at least 400?g/d of total fruits and vegetables.
Journal ArticleDOI

Awareness and current knowledge of breast cancer.

TL;DR: This review addresses anatomy of the breast, risk factors, epidemiology of breast cancer, pathogenesis of Breast cancer, stages of breastcancer, diagnostic investigations and treatment including chemotherapy, surgery, targeted therapies, hormone replacement therapy, radiation therapy, complementary therapies, gene therapy and stem-cell therapy etc for breast cancer.
Journal ArticleDOI

Weight Loss in Breast Cancer Patient Management

TL;DR: Although definitive weight loss intervention trials in breast cancer patients remain to be conducted, the current evidence relating increased body weight to adverse breast cancer outcome and the documented favorable effects of weight loss on clinical outcome in other comorbid conditions support consideration of programs for weight loss in Breast cancer patients.
References
More filters
Journal ArticleDOI

Mortality by cause for eight regions of the world: Global Burden of Disease Study

TL;DR: The Global Burden of Disease Study (GBD) used various data sources and made corrections for miscoding of important diseases (eg, ischaemic heart disease) to estimate worldwide and regional cause-of-death patterns in 1990, and the estimates by cause provide a foundation for a more informed debate on public-health priorities.
Journal ArticleDOI

Tamoxifen for early breast cancer: An overview of the randomised trials

TL;DR: The absolute improvement in recurrence was greater during the first 5 years, whereas the improvement in survival grew steadily larger throughout the first 10 years, and these benefits appeared to be largely irrespective of age, menopausal status, daily tamoxifen dose, and of whether chemotherapy had been given to both groups.
Journal Article

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Anthony Howell
- 16 May 1998 - 
TL;DR: There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated overview of their results is presented in this paper, which approximately doubles the amount of evidence from trials of about 5 years of tamoxifier and, taking all trials together, on events occurring more than 5 years after randomisation.
Journal Article

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, +226 more
- 18 Sep 1998 - 
TL;DR: The age-specific benefits of polychemotherapy appeared to be largely irrespective of menopausal status at presentation, oestrogen receptor status of the primary tumour, and of whether adjuvant tamoxifen had been given.
Related Papers (5)

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer

Eugenia E. Calle, +194 more
- 11 Oct 1997 -